These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 4607702

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic studies and autonomic function in children with partial lipodystrophy.
    West RJ, Fosbrooke AS, Lloyd JK.
    Arch Dis Child; 1974 Aug; 49(8):627-32. PubMed ID: 4418207
    [Abstract] [Full Text] [Related]

  • 3. Fat cell size and lipid content of subcutaneous tissue in congenital generalized lipodystrophy.
    Rognum TO, Bjerve KS, Seip M, Trygstad O, Oseid S.
    Acta Endocrinol (Copenh); 1978 May; 88(1):182-9. PubMed ID: 580534
    [Abstract] [Full Text] [Related]

  • 4. Effect of a specific dopaminergic blocking agent, pimozide, on hypothalamic corticotropin-releasing-factor activity in rats: clinical correlates.
    Upton GV, Corbin A.
    Experientia; 1975 Feb 15; 31(2):249-50. PubMed ID: 1078659
    [No Abstract] [Full Text] [Related]

  • 5. Letter: Management of lipoatrophic diabetes.
    Upton GV, Corbin A, Mabry CC, Hollingsworth DR.
    N Engl J Med; 1975 Mar 13; 292(11):592. PubMed ID: 1110678
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Congenital generalized lipodystrophy and experimental lipoatrophic diabetes in rabbits treated successfully with fenfluramine.
    Trygstad O, Foss I.
    Acta Endocrinol (Copenh); 1977 Jun 13; 85(2):436-48. PubMed ID: 577333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry.
    Pinder RM, Brogden RN, Swayer R, Speight TM, Spencer R, Avery GS.
    Drugs; 1976 Jun 13; 12(1):1-40. PubMed ID: 824116
    [Abstract] [Full Text] [Related]

  • 11. Metabolic and endocrine studies in a case of lipoatrophic diabetes.
    Rossini AA, Self J, Aoki TT, Goldman RF, Newmark SR, Meguid MM, Soeldner JS, Cahill GF.
    Metabolism; 1977 Jun 13; 26(6):637-50. PubMed ID: 870793
    [Abstract] [Full Text] [Related]

  • 12. The effects of depo-provera on carbohydrate, lipids and vitamin metabolism.
    Amatayakul K.
    J Steroid Biochem; 1979 Jul 13; 11(1B):475-81. PubMed ID: 491619
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome.
    Rizzo R, Eddy CM, Calí P, Gulisano M, Cavanna AE.
    Pediatr Neurol; 2012 Dec 13; 47(6):419-22. PubMed ID: 23127261
    [Abstract] [Full Text] [Related]

  • 16. Letter: Management of lipoatrophic diabetes.
    Senior B, Gellis SS.
    N Engl J Med; 1975 Jun 05; 292(23):1243. PubMed ID: 1128582
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of dopaminergic blocking agents on plasma luteinizing hormone releasing hormone activity in hypophysectomized rats.
    Corbin A, Upton GV.
    Experientia; 1973 Dec 05; 29(12):1552-3. PubMed ID: 4589326
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.